Between February 2004 and December 2015, 1,462 patients (male to female ratio 2.71 to 1) with NPC were included in the study.There were no significant differences between sexes in terms of T stage, N stage, clinical stage, pathological type, or chemotherapy dosage (Table 1). There were 680(male to female ratio 2.45 to 1), 473(male to female ratio 2.75 to 1), and 309(male to female ratio 3.35 to 1) patients in the premenopausal, menopausal, and postmenopausal groups, respectively.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile